Role of multivitamins and mineral supplements in preventing infections in elderly people: systematic review and meta-analysis of randomised controlled trials
BMJ 2005; doi: https://doi.org/10.1136/bmj.38399.495648.8F (Published 01 April 2005) Cite this as: BMJ 2005;:bmj;bmj.38399.495648.8Fv1
Data supplement
Posted as supplied by author.
The Role of Multivitamins and Mineral Supplements in Preventing Infections in The Healthy Elderly: A Systematic Review & Meta-Analysis of Randomised Control Trials
Alia El Kadiki, Alexander J Sutton
Appendix 1
Search strategy
Initial search from 1966 to February 2002:
Source
Host
Date searched
No. of references retrieved
Electronic bibliographic databases
AMED 1985-
Ovid BIOMED
11/02/02
7
Biological Abstracts 1985-
SilverPlatter WebSPIRS
13/02/02
10 RCTs 2 Epidemiol.
British Nursing Index 1985-
SilverPlatter WebSPIRS
13/02/02
0
Cinahl 1982-
Ovid BIOMED
11/02/02
40
Citation Indexes (Science and Social Science) 1981-
Web of Science
11/02/02
39
Cochrane Controlled Trials Register (CCTR)
The Cochrane Library CD ROM version 2001 Issue 4
11/02/02
216 RCTs
Cochrane Database of Systematic Reviews (CDSR)
The Cochrane Library CD ROM version 2001 Issue 4
11/02/02
12 (including 1 protocol)
Database of Abstract of Reviews of (DARE)
The Cochrane Library CD ROM version 2001 Issue 4
11/02/02
1
EBM Reviews
Ovid BIOMED
11/02/02
2
Embase 1988-
SilverPlatter WebSPIRS
14/02/02
170 RCTs 163 Epidemiol.
International Bibliographic Information on Dietary Supplements (IBIDS)
Ovid BIOMED
11/02/02
76
Medline 1966-
Ovid BIOMED
08/02/02
10 Reviews
153 RCTs
111 Epidemiol.
NHS CRD Databases: DARE, NHS EED, HTA
NHS Centre for Reviews and Dissemination (CRD) Web site
11/02/02
0 additional
PreMedline
Ovid BIOMED
11/02/02
4
Other sources
Bandolier
11/02/02
0
DEC Reports
13/02/02
0
E Guildeline
11/02/02
0
Health Evidence Bulletin, Wales
11/02/02
0
National Guildelines Clearinghouse
11/02/02
0
OMNI
13/02/02
0 relevant
ScHARR Library catalogue
ScHARR Library
11/02/02
0
SIGN
13/0202
0
TRIP Database
13/02/02
0 additional
TWGAP Reports
13/02/02
0
TOTAL NO. OF REFERENCES RETRIEVED (including duplicates)
1,016
Search Strategy Used in Midline (Ovid) < 1966 to present>
- exp vitamins/ (151282)
- vitamins$.tw. (66130)
- micronutients/ (416)
- or/1-3 (170821)
- exp trace elements/ (148034)
- trace element$.tw. (5425)
- exp antioxidants/ (61933)
- antioxidant$.tw. (25297)
- retinal.tw. (6447)
- exp ascorbic acid/ (20047)
- ascorbic acid.tw. (11170)
- tocopherol$.tw. (8012)
- menadione.tw. (1324)
- menaquinone.tw. (483)
- cobalt.tw. (9245)
- copper.tw. (25369)
- fluoride.tw. (17480)
- fluorine.tw. (3529)
- iodine.tw. (17022)
- iron.tw. (52427)
- manganese.tw. (8237)
- zinc.tw. (33788)
- selenium.tw. (9115)
- molybdenum.tw. (2335)
- chromium.tw. (6575)
- silicon.tw. (6575)
- exp minerals/ (51560)
- mineral$.tw. (39718)
- or/5-28 (366069)
- eating/ (23360)
- diatary supplements/ (3442)
- food.tw. (86122)
- food/ (12576)
- or/30-33 (110404)
- 29 and 34 (10098)
- 4 or 35 (177226)
- exp infection/(307738)
- infection$. tw. (415904)
- exp immunity/ (570166)
- "allergy and immunology"/(2871)
- im.fs. (785484)
- (immune or immunity or immunology$).ti. (106979)
- or/37-42 (1522096)
- 36 and 43 (13338)
- exp aged/ (1215692)
- elderly.tw.(1215692)
- old$ person$.tw. (3420)
- old$ people$. tw. (5210)
- or/45-48 (1226166)
- 44 and 49 (997)
- guideline.pt. (9980)
- practice guideline.pt. (6066)
- exp guidelines/ (27374)
- health planning guidelines/ (876)
- or/51-54 (37965)
- meta-analysis/ (3999)
- exp review literature/ (1350)
- (meta-analy$ or meta analy$ or metaanaly$).tw (7483)
- meta analysis.pt. (6071)
- review academic.pt.(60389)
- review literature.pt (26302)
- letter.pt. (444983)
- review of reported cases.pt. (43658)
- historical article.pt. (193586)
- review multicase.pt. (6620)
- or/56-61
- or 62-65
- 66 not 67 (97252)
- 55 or 68 (134197)
- 50 and 69 (11)
- limit 70 to (human and English language) (10)
- randomised controlled trial.pt. (152463)
- controlled clinical trial.pt. (59132)
- randomised controlled trials/ (20675)
- random allocation/ (44901)
- double blind method/ (67074)
- single blind method/ (6136)
- clinical trial.pt. (321481)
- (random$ adj5 trial$).tw.(47760)
- or/72-79 (374582)
- 50 and 80 (173)
- limit 81 to (human and English language) (153)
- exp epidemiologic studies/ (612374)
- (case$ adj3 control$).tw.(34604)
- epidemiolog$.ti.(49352)
- or/83-85 (669165)
- 50 and 86 (126)
- limit 87 to (human and English language) (111)
- from 71 keep 1-10 (10)
- from 82 keep 1-153 (153)
- from 88 keep 1-111 (111)
Search Strategy using database: CINAHL
- exp vitamins/ (3253)
- vitamin$.tw. (2044)
- micronutrients/ (185)
- or/1-3 (3960)
- exp trace elements/ (1211)
- trace element$. Tw. (67)
- antioxidants/ (682)
- antioxidant$.tw. (502)
- retinal.tw. (125)
- exp ascorbic acid/ (479)
- ascorbic acid.tw. (94)
- tocopherol$.tw. (102)
- menadione.tw. (0)
- menaquinone.tw. (2)
- cobalt.tw. (21)
- copper.tw. (163)
- fluoride.tw. (276)
- fluorine.tw. (10)
- iodine.tw. (211)
- iron.tw. (868)
- manganese.tw. (29)
- zinc.tw. (405)
- selenium.tw. (115)
- molybdenum.tw. (11)
- chromium.tw. (60)
- silicon.tw. (24)
- exp minerals/ (526)
- mineral$.tw. (955)
- or/5-28 (4604)
- eating/ (159)
- dietary supplemention/ (2136)
- food/ (1235)
- food.tw. (4903)
- or/ 30-33 (7704)
- 29 and 34 (904)
- exp infection/ (12508)
- infection$.tw. (14150)
- "allergy and immunology"/ (44)
- im.fs. (244)
- (immune or immunity or immunolog$).tw. (2613)
- exp immunity/ (2068)
- or/36-41 (24704)
- 4 or 35 (4331)
- exp aged/ (60050)
- elderly.tw. (11728)
- old$ person$.tw. (993)
- old$ people$.tw. (1979)
- or/44-47 (62151)
- 43 and 42 (234)
- 49 and 42 (40)
- from 50 keep 1-40 (40)
Search strategy for database AMED (Allied and Complementary Medicine)
< 1985 to December 2001>
- exp vitamins/ (1209)
- vitamin$.tw. (1160)
- micronutrients/ (6)
- or/1-3 (1364)
- exp trace elements/ (401)
- trace element$. Tw. (138)
- antioxidants/ (193)
- antioxidant$. Tw. (363)
- retinal.tw. (3)
- exp ascorbic acid/ (162)
- ascorbic acid.tw. (183)
- tocopherol$.tw. (27)
- menadione.tw. (3)
- menaquinone.tw. (0)
- cobalt.tw. (19)
- copper.tw. (76)
- fluoride.tw. (22)
- fluorine.tw. (3)
- iodine.tw. (32)
- iron.tw. (90)
- manganese.tw. (13)
- zinc.tw. (127)
- selenium.tw. (107)
- molybdenum.tw. (7)
- chromium.tw. (37)
- silicon.tw. (12)
- exp minerals/ (484)
- mineral$.tw. (843)
- or/5-28 (1795)
- eating/ (57)
- food/ (355)
- food.tw. (1061)
- exp diet/ (937)
- or/30-33 (1893)
- 29 and 34 (205)
- 4 or 35 (1474)
- exp aged/ (4323)
- elderly.tw. (2352)
- old$ person$. Tw. (238)
- old$ people$. tw. (354)
- or/37-40 (4991)
- 36 and 41 (58)
- exp infection/ (252)
- infection$.tw. (1842)
- exp immunity/ (331)
- exp immune system/ (831)
- (immunity or immune or immunology$). Tw. (1599)
- or/43-47 (3510)
- 42 and 48 (7)
- from 49 keep 1-7 (7)
Search strategy by PREMEDLINE
- (vitamin$ or mineral$ or trace element$ or micronutrient$).tw. (2079)
- (immunity or immune or immunology$ or infection$).tw. (9918)
- (elderly or old$ people$ or old person$).tw. (1394)
- 1 and 2 and 3 (4)
- from 4 keep 1-4 (4)
search strategy – database: EMB reviews – ACP Journal club
<1991 to September/October 2001>
- [exp vitamin/] (0)
- vitamin$.tw. (91)
- [micronutrients/] (0)
- or/1-3 (91)
- [exp trace elements/] (0)
- trace element$. Tw. (3)
- [antioxidants/] (0)
- antioxidant$.tw (26)
- retinal.tw. (5)
- [exp ascorbic acid/] (0)
- ascorbic acid.tw. (4)
- tocopherol$.tw. (9)
- menadione.tw. (0)
- menaquinone.tw. (0)
- cobalt.tw. (0)
- copper.tw. (3)
- fluoride.tw. (7)
- fluorine.tw. (0)
- iodine.tw. (14)
- iron.tw. (21)
- manganese.tw. (0)
- zinc.tw. (11)
- selenium.tw. (7)
- molybdenum.tw. (0)
- chromium.tw. (0)
- silicon.tw. (0)
- [exp minerals/] (0)
- mineral$.tw. (40)
- or/5-28 (111)
- [eating/] (0)
- [food/] (0)
- food.tw. (95)
- [exp diet/] (0)
- or/30-33 (95)
- 29 and 34 (14)
- 4 or 35 (95)
- [exp aged/] (0)
- elderly.tw. (212)
- old$ person$.tw. (42)
- old$ people$.tw. (2)
- or/37-40 (228)
- 36 and 41 (14)
- [exp infection/] (0)
- infection$.tw. (364)
- [exp immunity/] (0)
- [exp immune system/] (0)
- (immunity or immune or immunology$). Tw. (106)
- or/43-47 (397)
- 42 and 48 (2)
- [from 49 keep 1-7] (0)
- from 49 keep 1-2 (2)
Search Strategy Used in Midline (Ovid)
- exp vitamins/ (151282)
- vitamins$.tw. (66130)
- micronutients/ (416)
- or/1-3 (170821)
- exp trace elements/ (148034)
- trace element$.tw. (5425)
- exp antioxidants/ (61933)
- antioxidant$.tw. (25297)
- retinal.tw. (6447)
- exp ascorbic acid/ (20047)
- ascorbic acid.tw. (11170)
- tocopherol$.tw. (8012)
- menadione.tw. (1324)
- menaquinone.tw. (483)
- cobalt.tw. (9245)
- copper.tw. (25369)
- fluoride.tw. (17480)
- fluorine.tw. (3529)
- iodine.tw. (17022)
- iron.tw. (52427)
- manganese.tw. (8237)
- zinc.tw. (33788)
- selenium.tw. (9115)
- molybdenum.tw. (2335)
- chromium.tw. (6575)
- silicon.tw. (6575)
- exp minerals/ (51560)
- mineral$.tw. (39718)
- or/5-28 (366069)
- eating/ (23360)
- diatary supplements/ (3442)
- food.tw. (86122)
- food/ (12576)
- or/30-33 (110404)
- 29 and 34 (10098)
- 4 or 35 (177226)
- exp infection/(307738)
- infection$. tw. (415904)
- exp immunity/ (570166)
- "allergy and immunology"/(2871)
- im.fs. (785484)
- (immune or immunity or immunology$).ti. (106979)
- or/37-42 (1522096)
- 36 and 43 (13338)
- exp aged/ (1215692)
- elderly.tw.(1215692)
- old$ person$.tw. (3420)
- old$ people$. tw. (5210)
- or/45-48 (1226166)
- 44 and 49 (997)
- guideline.pt. (9980)
- practice guideline.pt. (6066)
- exp guidelines/ (27374)
- health planning guidelines/ (876)
- or/51-54 (37965)
- meta-analysis/ (3999)
- exp review literature/ (1350)
- (meta-analy$ or meta analy$ or metaanaly$).tw (7483)
- meta analysis.pt. (6071)
- review academic.pt.(60389)
- review literature.pt (26302)
- letter.pt. (444983)
- review of reported cases.pt. (43658)
- historical article.pt. (193586)
- review multicase.pt. (6620)
- or/56-61
- or 62-65
- 66 not 67 (97252)
- 55 or 68 (134197)
- 50 and 69 (11)
- limit 70 to (human and English language) (10)
- randomised controlled trial.pt. (152463)
- controlled clinical trial.pt. (59132)
- randomised controlled trials/ (20675)
- random allocation/ (44901)
- double blind method/ (67074)
- single blind method/ (6136)
- clinical trial.pt. (321481)
- (random$ adj5 trial$).tw.(47760)
- or/72-79 (374582)
- 50 and 80 (173)
- limit 81 to (human and English language) (153)
- exp epidemiologic studies/ (612374)
- (case$ adj3 control$).tw.(34604)
- epidemiolog$.ti.(49352)
- or/83-85 (669165)
- 50 and 86 (126)
- limit 87 to (human and English language) (111)
UPDATED SEARCH FROM 2002 – 2004:
Database: Ovid MEDLINE(R) <1996 to January Week 2 2004>
Search Strategy:
--------------------------------------------------------------------------------
1 exp vitamins/ (40543)
2 vitamin$.tw. (25176)
3 micronutrients/ (681)
4 or/1-3 (50247)
5 exp trace elements/ (40004)
6 trace elements$.tw. (1424)
7 exp antioxidants/ (34459)
8 antioxidant$.tw. (22433)
9 retinal.tw. (21468)
10 exp ascorbic acid/ (5990)
11 ascorbic acid.tw. (3842)
12 tocopherol$.tw. (4412)
13 menadione.tw. (590)
14 menaquinone.tw. (268)
15 cobalt.tw. (2625)
16 copper.tw. (10225)
17 fluoride.tw. (4463)
18 fluorine.tw. (1431)
19 iodine.tw. (5552)
20 iron.tw. (21847)
21 manganese.tw. (3711)
22 zinc.tw. (15493)
23 selenium.tw. (3639)
24 molybdenum.tw. (871)
25 chromium.tw. (2386)
26 silicon.tw. (2093)
27 exp minerals/ (16164)
28 mineral$.tw. (20812)
29 or/5-28 (164457)
30 eating/ (8765)
31 dietary supplements/ (6272)
32 food.tw. (43309)
33 food/ (3332)
34 or/30-33 (54643)
35 29 and 34 (7003)
36 4 or 35 (54361)
37 exp infection/ (101720)
38 infection$.tw. (190220)
39 exp immunity/ (154703)
40 "allergy and immunology"/ (846)
41 im.fs. (245909)
42 (immune or immunity or immunolog$).ti. (26574)
43 or/37-42 (503007)
44 36 and 43 (4223)
45 exp aged/ (455353)
46 elderly.tw. (35799)
47 old$ people$.tw. (3522)
48 old$ person$.tw. (1957)
49 or/45-48 (461164)
50 44 and 49 (415)
51 guideline.pt. (6970)
52 practice guideline.pt. (5375)
53 exp guidelines/ (30620)
54 health planning guidelines/ (547)
55 or/51-54 (37878)
56 meta-analysis/ (3146)
57 exp review literature/ (1428)
58 (meta-analy$ or meta analy$ or metaanaly$).tw. (7759)
59 meta analysis.pt. (6233)
60 review academic.pt. (40374)
61 review literature.pt. (22243)
62 letter.pt. (188571)
63 review of reported cases.pt. (23107)
64 historical article.pt. (45150)
65 review multicase.pt. (3043)
66 or/56-61 (74223)
67 or/62-65 (257025)
68 66 not 67 (72813)
69 55 or 68 (109361)
70 50 and 69 (5)
71 limit 70 to english language (5)
72 randomized controlled trial.pt. (86088)
73 controlled clinical trial.pt. (19356)
74 randomized controlled trials/ (22039)
75 random allocation/ (14486)
76 double blind method/ (30793)
77 single blind method/ (5098)
78 clinical trial.pt. (167258)
79 (random$ adj5 trial$).tw. (39368)
80 or/72-79 (214191)
81 50 and 80 (102)
82 limit 81 to (human and english language) (100)
83 exp epidemiologic studies/ (364174)
84 (case$ adj3 control$).tw. (22537)
85 epidemiolog$.ti. (15518)
86 or/83-85 (382375)
87 50 and 86 (81)
88 limit 87 to (human and english language) (68)
89 from 71 keep 1-5 (5)
90 71 or 82 or 88 (155)
91 limit 90 to yr=2002-2004 (39)
92 from 91 keep 1-39 (39)Database: Amed ( to January week 2 2004)
1
vitamin$
1511
2
micronutrient$
55
3
micronutrients.DE.
8
4
1 OR 2 OR 3
1533
5
trace ADJ element$
166
6
antioxidant$
813
7
retinal
76
8
ascorbic ADJ acid$
273
9
tocopherol$
63
10
menadione
4
11
menaquinone
0
12
cobalt
22
13
copper
105
14
fluoride
40
15
fluorine$
8
16
iodine
45
17
iron
134
18
selenium
140
19
molybdenum
7
20
chromium
52
21
silicon$
110
22
mineral$
1095
23
5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22
2703
24
eating
432
25
food$
1619
26
diet$
3793
27
24 OR 25 OR 26
5122
28
23 AND 27
663
29
4 OR 28
1876
30
aged.DE.
5444
31
elderly
3123
32
old$ ADJ person$
332
33
old$ ADJ people$
626
34
30 OR 31 OR 32 OR 33
6654
35
29 AND 34
95
36
infections.DE.
1662
37
infection$
2641
38
immunity.DE.
355
39
(immune ADJ system).DE.
726
40
immunity OR immune OR immunology
1542
41
36 OR 37 OR 38 OR 39 OR 40
3989
42
41 AND 35
12
43
42 AND 2002 onwards
8
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations <February 3, 2004>
Search Strategy:
--------------------------------------------------------------------------------
1 (vitamin$ or mineral$ or trace element$ or micronutrient$).mp. [mp=title, abstract] (3893)
2 (immunity or immune or immunology or infection$).mp. [mp=title, abstract] (14884)
3 (elderly or old people$ or old person$).mp. [mp=title, abstract] (2298)
4 1 and 2 and 3 (6)
5 from 4 keep 1-6 (6)"((Aged#.W..DE. OR Aged-80-And-Over#.DE. OR Aged-80-And-Over#.DE.) OR (elderly.TI,AB,DE.) OR (( old ADJ person$ OR old ADJ people$ ) .TI,AB,DE.)) AND (((infection$.TI,AB,DE.) OR (Infection#.W..DE.) OR (Allergy-and-Immunology#.DE.) OR (im.FS.) OR (( immune OR immunity OR immunolog$ ) .TI,AB,DE.) OR (Immunity#.W..DE.)) AND (((vitamin$.TI,AB.) OR (micronutrients#.DE.) OR (vitamins#.DE.)) OR (((( trace ADJ element$ ) .TI,AB.) OR (TRACE-ELEMENTS#.DE.) OR (antioxidant$.TI,AB.) OR (ANTIOXIDANTS#.W..DE.) OR (retinal.TI,AB.) OR (( ascorbic ADJ acid$ ) .TI,AB.) OR (ASCORBIC-ACID#.DE.) OR (tocopherol$.TI,AB.) OR (menadione.TI,AB.) OR (menaquinone.TI,AB.) OR (cobalt.TI,AB,DE.) OR (copper.TI,AB,DE.) OR (fluoride.TI,AB,DE.) OR (fluorine.TI,AB,DE.) OR (iodine.TI,AB,DE.) OR (iron.TI,AB,DE.) OR (manganese.TI,AB,DE.) OR (zinc.TI,AB,DE.) OR (selenium.TI,AB,DE.) OR (molybdenum.TI,AB,DE.) OR (chromium.TI,AB,DE.) OR (silicon.TI,AB,DE.) OR (mineral$.TI,AB,DE.) OR (MINERALS#.W..DE.)) AND ((Eating#.W..DE.) OR (Dietary-Supplementation#.DE.) OR (food.TI,AB,DE.)))))":
document 1 of 37
CINAHL (R) - 2002 to date (NAHL)Searches carried out, removing language restriction filters (done in order to respond to reviewers comments on the initial submission on the paper)
Search for: 70 or 81 or 87
Results: 1-366
Database: Ovid MEDLINE(R) <1966 to November Week 3 2004>
Search Strategy:
--------------------------------------------------------------------------------
1 exp vitamins/ (163976)
2 vitamin$.tw. (78903)
3 micronutrients/ (903)
4 or/1-3 (188890)
5 exp trace elements/ (170641)
6 trace elements$.tw. (4680)
7 exp antioxidants/ (94753)
8 antioxidant$.tw. (39189)
9 retinal.tw. (63822)
10 exp ascorbic acid/ (22886)
11 ascorbic acid.tw. (13027)
12 tocopherol$.tw. (10032)
13 menadione.tw. (1661)
14 menaquinone.tw. (661)
15 cobalt.tw. (10368)
16 copper.tw. (31360)
17 fluoride.tw. (19575)
18 fluorine.tw. (4190)
19 iodine.tw. (19460)
20 iron.tw. (65516)
21 manganese.tw. (10270)
22 zinc.tw. (44232)
23 selenium.tw. (10938)
24 molybdenum.tw. (2890)
25 chromium.tw. (7824)
26 silicon.tw. (4807)
27 exp minerals/ (61252)
28 mineral$.tw. (51357)
29 or/5-28 (514045)
30 eating/ (27056)
31 dietary supplements/ (7987)
32 food.tw. (109406)
33 food/ (13984)
34 or/30-33 (139738)
35 29 and 34 (14363)
36 4 or 35 (197827)
37 exp infection/ (366138)
38 infection$.tw. (512197)
39 exp immunity/ (627969)
40 "allergy and immunology"/ (3256)
41 im.fs. (908276)
42 (immune or immunity or immunolog$).ti. (120598)
43 or/37-42 (1771974)
44 36 and 43 (14730)
45 exp aged/ (1419230)
46 elderly.tw. (93000)
47 old$ people$.tw. (7222)
48 old$ person$.tw. (4339)
49 or/45-48 (1432697)
50 44 and 49 (1188)
51 guideline.pt. (13097)
52 practice guideline.pt. (8831)
53 exp guidelines/ (44014)
54 health planning guidelines/ (1822)
55 or/51-54 (58415)
56 meta-analysis/ (5789)
57 exp review literature/ (2229)
58 (meta-analy$ or meta analy$ or metaanaly$).tw. (12493)
59 meta analysis.pt. (10133)
60 review academic.pt. (86844)
61 review literature.pt. (40856)
62 letter.pt. (525704)
63 review of reported cases.pt. (51552)
64 historical article.pt. (214668)
65 review multicase.pt. (8821)
66 or/56-61 (146144)
67 or/62-65 (794688)
68 66 not 67 (143795)
69 55 or 68 (200270)
70 50 and 69 (14)
71 limit 70 to english language (13)
72 randomized controlled trial.pt. (199108)
73 controlled clinical trial.pt. (68418)
74 randomized controlled trials/ (35851)
75 random allocation/ (52891)
76 double blind method/ (81478)
77 single blind method/ (8717)
78 clinical trial.pt. (401069)
79 (random$ adj5 trial$).tw. (71139)
80 or/72-79 (483337)
81 50 and 80 (228)
82 limit 81 to (human and english language) (205)
83 exp epidemiologic studies/ (790418)
84 (case$ adj3 control$).tw. (46871)
85 epidemiolog$.ti. (56255)
86 or/83-85 (855622)
87 50 and 86 (165)
88 limit 87 to (human and english language) (148)
89 from 71 keep 1-5 (5)
90 71 or 82 or 88 (326)
91 limit 90 to yr=2002-2004 (73)
92 70 or 81 or 87 (366)
93 from 92 keep 1-366 (366)Search for: from 45 [38 or 44] keep 1-41
Results: 1-41
Database: CINAHL - Cumulative Index to Nursing & Allied Health Literature <1982 to December Week 1 2004>
Search Strategy:
--------------------------------------------------------------------------------
1 micronutrients.mp. or exp MICRONUTRIENTS/ (436)
2 vitamins.mp. or exp VITAMINS/ (6055)
3 trace elements.mp. or exp Trace Elements/ (2145)
4 antioxidants.mp. or exp ANTIOXIDANTS/ (1554)
5 retinal.mp. (383)
6 ascorbic acid.mp. or exp Ascorbic Acid/ (880)
7 tocopherol.mp. or exp Vitamin E/ (949)
8 menadione.mp. or exp Vitamin K/ (263)
9 menaquinone.mp. (3)
10 cobalt.mp. or exp COBALT/ (51)
11 copper.mp. or exp COPPER/ (323)
12 fluoride.mp. or exp Fluorides/ (670)
13 fluorine.mp. (18)
14 iodine.mp. or exp IODINE/ (434)
15 exp IRON/ or iron.mp. (1677)
16 manganese.mp. or exp MANGANESE/ (64)
17 zinc.mp. or exp ZINC/ (887)
18 exp SELENIUM/ or selenium.mp. (305)
19 molybdenum.mp. (14)
20 exp CHROMIUM/ or chromium.mp. (171)
21 exp SILICON/ or silicon.mp. (71)
22 minerals.mp. or exp MINERALS/ (1149)
23 or/1-22 (11484)
24 exp EATING/ or eating.mp. (4364)
25 dietary supplementation.mp. or exp Dietary Supplementation/ (4849)
26 diet.mp. or exp DIET/ (15408)
27 food.mp. or exp FOOD/ (22609)
28 or/24-27 (36721)
29 23 and 28 (4744)
30 exp INFECTION/ or infection.mp. (29772)
31 (allergy and immunology).mp. [mp=title, cinahl subject headings, abstract, instrumentation] (107)
32 im.fs. (1890)
33 immunity.mp. or exp IMMUNITY/ (3632)
34 immunology.mp. or exp "Allergy and Immunology"/ (421)
35 immune.tw. (2877)
36 or/30-35 (35560)
37 29 and 36 (269)
38 limit 37 to (aged <65 to 79 years> or "aged <80 and over>") (36)
39 exp "AGED, 80 AND OVER"/ or exp AGED/ (95705)
40 elderly.mp. (16447)
41 old$ people$.mp. (3613)
42 old$ person$.mp. (1529)
43 or/39-42 (98772)
44 37 and 43 (41)
45 38 or 44 (41)
46 from 45 keep 1-41 (41)
47 from 46 keep 1-41 (41)
48 from 46 keep 1-41 (41)Amed search -
No.
Search term
Results
1
vitamin$
1554
2
micronutrient$
61
3
micronutrients.DE.
8
4
trace ADJ element$
174
5
antioxidant$
875
6
retinal
80
7
ascorbic ADJ acid$
273
8
tocopherol$
66
9
menadione
4
10
cobalt
25
11
menaquinone
0
12
copper
103
14
fluoride
42
15
fluorine$
9
16
iodine
47
17
iron
136
18
selenium
150
19
molybdenum
7
20
chromium
54
21
silicon$
118
22
mineral$
1168
23
1 OR 2 OR 3
1578
24
4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22
2869
25
eating
460
27
food$
1692
28
diet$
3940
29
25 OR 27 OR 28
5330
31
24 AND 29
691
32
23 OR 31
1942
33
aged.DE.
5951
34
elderly
3321
35
old$ ADJ people
692
36
old$ ADJ person$
353
37
33 OR 34 OR 35 OR 36
7234
38
32 AND 37
103
39
infections.DE.
1794
40
infection$
2849
41
(immune ADJ system).DE.
737
42
immunity OR immune OR immunology
1605
43
immunology.DE.
1
44
39 OR 40 OR 41 OR 42 OR 43
4253
45
38 AND 44
14
Assessing concerns regarding the validity of three trials included in "Role of multivitamins and mineral supplements in preventing infections in elderly people: systematic review and meta-analysis of randomised controlled trials"
Alexander J Sutton, Alia El Kadiki
Department of Health Sciences, University of Leicester, 22- 28 Princess Road West, Leicester, LE1 6TP, UKAlexander J Sutton
senior lecturer in medical statistics
Chemical Pathology Department, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UKAlia El Kadiki
specialist registrar
Correspondence to: Alexander J Sutton (ajs22{at}le.ac.uk)
Background
This article is a follow up to the systematic review and meta-analysis of the use of multivitamins and mineral supplements in preventing infections in elderly people published recently in the BMJ.1 Following the publication of this paper it came to the attention of both the BMJ and the authors that doubts regarding the validity of three of the trials2-4 included in the systematic review and meta-analyses had been raised publicly (see below). It is the aim of this article to assess the impact these allegations, if true, would have on the results of our systematic review and meta-analysis. We do not know whether the allegations made against the trials are true, but, after discussions with the editors of the BMJ, we were satisfied that there are enough published concerns relating to these studies to warrant the sensitivity analysis presented here.
Concerns about studies included in the systematic review/meta-analysis
Concerns have arisen about three trials included in our systematic review. Concerns were raised5 about the trial published by Chandra in the Lancet in 1992 2 relating to inconsistencies in the statistical analysis results and other anomalies. Although these were largely dismissed by Chandra in a letter of response,6 further concerns were raised7,8 regarding a follow-up paper by Chandra9 concerning the same trial but relating to different (cognitive) outcomes. As a result, Nutrition10 has recently retracted this follow-up paper.
A further trial3 by Chandra was also included in our meta-analysis. Specific concerns have been raised regarding this trial also,8 in addition to the fact that it was essentially a replication of a trial under scrutiny.
One of the rapid responses, following a news item in the BMJ11 highlighting concerns regarding Chandra’s now retracted article,9 was by Roberts and Sternberg12 (who had published some of the initial concerns regarding Chandra’s research). In this response they raised concerns relating to a trial report by (Amrit L) Jain4 which replicated Chandra’s 1992 Lancet results.2 This trial was published in Nutrition Research, which at the time was edited by Chandra. They also stated: (i) they were unable to find any other "trace" of Jain; (ii) the mailing address on the article was a rented mailbox not far from Memorial University where Chandra was employed; and (iii) they have been unable to locate any other trace of the institution affiliation given to Jain in his article. However, to date, none of the three trial reports2-4 included in our original systematic review have been retracted by the journals in which they were published.
Sensitivity analysis
Since none of the papers under scrutiny have been retracted by the journals they were published in, we are taking the stance that the analysis including such studies, as published in our original article, is still an appropriate primary analysis (see Discussion). However, had we known about the allegations at the time of writing the original paper, we would have conducted a careful sensitivity analysis investigating the influence such allegations would have, if true, on the evidence base. It is this sensitivity analysis we present here. We consider the three outcomes meta-analysed in the original paper in turn.
Outcome one: Mean difference in number of days spent with infection
Only the three trials under scrutiny contribute data to this outcome. Unaware of the allegations made by others, we independently commented in our original paper that the standard deviations looked very small for all studies reporting the outcome mean difference in number of days spent with infections on multivitamins and minerals compared with placebo over 12 months. We commented that these standard deviations may, in fact, be standard errors and performed a sensitivity analysis adjusting the analysis accordingly. In fact, Chandra, in a letter to the Lancet,6 had acknowledged this mistake had been made in his 1992 study but we were unaware of this letter at the time of the original analysis. As we reported previously,1 by inflating the errors in the study estimates in this way for all three trials, the pooled reduction in days of infection over 12 months changed from 17.5 (11 to 24) to 14 (10 to 18). (Figure 1)
Obviously, such a revised analysis is only appropriate if this were a reporting error in the three trials. The more serious allegations raised against these studies would seem to imply that the data were not legitimate. The impact of such accusations is clear. Since all studies individually show a statistically significant benefit then removing any one or two of them would still result in a suggested benefit for this outcome. Clearly, if all three trials were removed then no valid data would be available for this outcome.
Outcome two: Odds ratio of at least one infection in the study period
None of the trials under scrutiny contributed to this outcome, so the pooled odds ratio for one or more infections in the study period remains at 1.10 (0.81 to 1.50), suggesting little support for the benefit of multivitamins and minerals, with no sensitivity analysis required.
Outcome three: Incidence rate ratio for the difference in infection rates
The only trial under scrutiny that contributed to this outcome – the incidence rate ratio of infection for vitamins and minerals compared to placebo – was that by Jain.4 We now reanalyse this outcome removing this trial and combining the remaining three trials. In the revised analysis, the pooled incidence rate ratio is 1.00 (0.85 to 1.17) (Figure 2) compared to 0.89 (0.78 to 1.03) when all studies were included. Hence, removing the Jain trial (which had the most beneficial outcome), has had a large impact on the pooled estimate, with any suggestion of multivitamins being beneficial removed.
Summary
All four estimates of effect reported across the three outcomes in the three trials under scrutiny suggested a statistically significant benefit, while the six other estimates reported in the other five trials in the systematic review did not. If the allegations are true that these three studies are not reliable, then the remaining evidence base suggests no benefit for the use of multivitamins for preventing infections in the elderly. Under the less extreme situation that one or more of the three trials is valid, this would still provide some evidence that multivitamins may be beneficial and further investigation may be warranted.
Discussion
In this article we have aimed to explore the impact concerns about the validity of a number of studies would have on our previous meta-analysis, if they were true. If the three studies are indeed completely invalid, then this would change the evidence base from conflicting and heterogeneous to more homogeneous, with little suggestion that multivitamins and minerals are effective for reducing infection in the elderly. Also, the conclusions of our review potentially change, if the studies are invalid, since the case for concluding further research in this topic would be weak.
Implications for dealing with suspected fraudulent papers in future systematic reviews
It is unfortunate that the published concerns5,7,8,11,12 regarding the trials had escaped the attention of ourselves, the peer reviewer, and the editorial committee at the BMJ who dealt with our original paper.1 This situation did however mean we were not influenced by the mostly un-proven allegations. Since we used a search strategy designed to identify reports of randomised controlled trials, it is perhaps not surprising we missed the published discussion relating to them using this search. However in our re-assessment of the situation we acknowledge that Medline did provide a link that we missed to some of the correspondence in one of the trials’ 2 database entry (although this may have been added after we did our initial literature searches). Hence, although we hope that situations such as this are rare, we would like to flag up this issue for other systematic reviews so similar oversights are not made in the future. As well as using electronic databases to identify potential trials, and reading the abstracts available as an initial screening tool (as we did), the whole database record should be checked for links to publications relating to it, since this is information in the database record that is not available in the published paper. We strongly suggest this issue be highlighted in systematic review guidelines.13,14
As stated above, even if we had known about the allegations before publishing our initial paper, we would not have modified our primary analysis, since none of the three studies have been retracted, but we would have included the sensitivity analyses described here. We are unaware of any systematic review guidelines that provide guidance regarding how to deal with evidence from studies in which allegations of fraudulent research have been made. It would seem reasonable to assume that if a paper is formally retracted by a journal then it is no longer part of the published evidence base. It is less clear how unproven allegations should be dealt with. When we discovered the controversy that surrounded these studies, we wrote to the editors of the two journals in which the trial reports (Nutrition Research and the Lancet) were published to confirm that none of the papers had been retracted. They confirmed that these papers had not been retracted.
The most serious allegations suggest the three studies were essentially never done. This is well beyond the more usual concerns regarding study quality; that is, due to imperfect methodology, a study may be at risk of producing biased findings. Such accusations do not come into the usual quality appraisal of studies included in a systematic review. Using the Jadad score to measure quality, 15 both papers by Chandra scored 4 out of 5 while the study by Jain scored 2 out of 5. We considered the latter’s low score was at least in part attributable to the short length of the available trial report. Such instruments only really assess quality of reporting and not quality of the research and rely on the honesty of the trial investigators. Hence, the standard methods used for the selection of studies in a systematic review are inadequate under such extraordinary situations, which is why we have provided the sensitivity analysis described here.
Methods to detect fraudulent data in statistical datasets have been developed, but we know of no such methods to examine fraud across a series of meta-analyses of summary results. The fact that three out of a total of eight trials are under scrutiny, and these trials reported an outcome not reported by any other study, means using statistical methods to examine how extreme outlying trial results are is not possible. While the problem of "missing" studies, or publication bias, has received a lot of attention in meta-analysis, with methods developed to detect and address it, 16 the issue of having "extra" made-up studies is more unusual, with no formal methodology developed to address this situation.
Although we consider the sensitivity analysis conducted here to be very insightful, perhaps a more sophisticated alternative would be to use Bayesian statistical methods to provide a framework for including external information, such as expert beliefs regarding the likelihood that the studies are invalid.17 Unfortunately we did not have time to pursue this idea for this paper .
.Implications for research and practice
We appreciate it is unclear whose responsibility it is to further investigate and reach a verdict regarding the validity of the three trials. However, we do hope some verdict can be reached soon, since this sensitivity analysis has show that they have a crucial impact on the total evidence base and conclusions that can be drawn from it.
We would like to acknowledge Professor Saul Sternberg for initially bringing this issue to our attention, having read the original paper when first published on the BMJ website, and Dr Nicola Cooper for providing advice when writing this article.
Contributors: Analysis, interpretation, drafting and revising of the article were all carried out be AEK & AJS. AEK and AJS are joint first authors of the paper. AJS is the guarantor.Funding: None
Competing interests: Alex Sutton is an editor of the book, Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments, which will be published later this year for which he has received a payment and will receive a royalties.
Ethical approval: Not required.
1. El-Kadiki A, Sutton AJ. Role of multivitamins and mineral supplements in preventing infections in elderly people: systematic review and meta-analysis of randomised controlled trials. BMJ 2005;330:871-6
2. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infecton in elderly subjects. Lancet 1992;340:1124-7.
3. Chandra RK. Influence of multinutrient supplement on immune responses and infection-related illness in 50-65 year old individuals. Nutrition Research 2002;22:5-11.
4. Jain AL. influence of vitamins and trace-elements on the incidence of respiratory infection in the elderly. Nutrition Research 2002;22:85-7.
5. Carpenter KJ, Roberts S, Sternberg S. Nutrition and immune function: a 1992 report. Lancet 2003; 361:2247.
6. Chandra RK. Author reply to Nutrition and immune function: a 1992 report. Lancet 2003; 361:2247-8.
7. Shenkin SD, Whiteman MC, Pattie A, Deary IJ. Supplementation and the elderly: dramatic results? Nutrition 2002;18:364-5.
8. Roberts S, Sternberg S. Do nutritional supplements improve cognitive function in the elderly? Nutrition 2003; 19:976-8.
9. Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 2001;17:709-12.
10. Meguid MM. Retraction. Nutrition 2005;21:286.
11. White C. Three journals raise doubts on validity of Canadian studies. BMJ 2004;328:67.
12. Roberts SD, Sternberg S. How and what to investigate. BMJ – rapid response to "White C. Three journals raise doubts on validity of Canadian studies. BMJ 2004;328:67." http://bmj.bmjjournals.com/cgi/eletters/328/7431/67 [Accessed 20 April 2005]
13. Khan KS, Riet, G, Glanville J, Sowden AJ, Kleijen J. Undertaking systematic reviews of research on effectiveness. York: University of York, 2001.
14 The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Version 4.3.4 (March 2005) (http://www.cochrane.org/resources/handbook/handbook.pdf)
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomised clinical trials: Is blinding necessary? Controlled clinical trials 1996;17:1-12.
16. Sutton, A.J., Song, F., Gilbody, S.M. and Abrams, K.R. Modelling publication bias in meta-analysis: a review. Statistical methods in medical research 2000;9: 421-45.
17. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation., Chichester: Wiley, 2003.
Figure 1 Random effects meta-analysis of outcome: mean difference in number of days of infection between multivitamin + supplement and placebo groups in 12 months assuming reported standard deviations for all trials were actually standard errors.
Footnote: the confidence interval round the pooled estimate is narrower after inflating the uncertainty in the study estimates. This may seem counter intuitive; however, this is because the statistical heterogeneity between study estimates is greatly reduced by such error inflation as this is reflected in the random effect pooled estimate.)
Figure 2 Fixed effect meta-analysis of outcome: incidence rate ratio for infection between multivitamin + supplement and placebo groups excluding the study by Jain
Related articles
- Editorial Published: 27 July 2002; BMJ 325 doi:10.1136/bmj.325.7357.173
- This Week In The BMJ Published: 14 April 2005; BMJ 330 doi:10.1136/bmj.330.7496.0
- Education And Debate Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.557
- Editorial Published: 04 August 2005; BMJ 331 doi:10.1136/bmj.331.7512.304
- Primary Care Published: 04 August 2005; BMJ 331 doi:10.1136/bmj.331.7512.324
- Correction Published: 14 July 2005; BMJ 331 doi:10.1136/bmj.331.7509.142
See more
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisBMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188
- NHS to fund large trial of pre-exposure prophylaxis for HIV preventionBMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537
- Bill to boost medical research funding and speed drug approval passes US houseBMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498
- Alpha blockers for treatment of ureteric stones: systematic review and meta-analysisBMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112
- Sixty seconds on . . . solanezumabBMJ November 29, 2016, 355 i6389; DOI: https://doi.org/10.1136/bmj.i6389
Cited by...
- Effect of fruit and vegetable consumption on immune function in older people: a randomized controlled trial
- Reporting of systematic reviews of micronutrients and health: a critical appraisal
- Multivitamin and multimineral supplements did not reduce reported infection days or related use of healthcare services in elderly people
- Review: multivitamins and mineral supplements do not reduce infections in elderly people
- Vitamin and mineral supplements for preventing infections in older people
- Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial
- From the Library
- Do Vitamin and Mineral Supplements Reduce Infections in Elders?